247499
Ethyl cellulose
viscosity 100 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Recommended Products
form
powder or granules
Quality Level
autoignition temp.
698 °F
concentration
48.0-49.5%
extent of labeling
48% ethoxyl
refractive index
n20/D 1.47 (lit.)
viscosity
100 cP, 5 % in toluene/ethanol 80:20(lit.)
transition temp
softening point 155 °C
density
1.14 g/mL at 25 °C (lit.)
Looking for similar products? Visit Product Comparison Guide
General description
Ethyl cellulose is a non-toxic, physiologicallyinert, and stable hydrophobic polymer. It is widely used in the preparation ofsustained release matrices for drug delivery systems.
Application
Ethyl cellulose can be used:
- To prepare polymeric microcapsules of Alachlor and Metolachlor to study their controlled-release properties.
- As a core matrix to synthesize biphasic drug release nanofibers.
- To prepare wax-based solid dispersion pellets with excellent floating and sustained-release ability.
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Päivi Grönroos et al.
Sensors (Basel, Switzerland), 19(12) (2019-06-30)
Novel hot electron-emitting working electrodes and conventional counter electrodes were created by screen printing. Thus, low-cost disposable electrode chips for bioaffinity assays were produced to replace our older expensive electrode chips manufactured by manufacturing techniques of electronics from silicon or
Robert Morhard et al.
IEEE transactions on bio-medical engineering, 67(8), 2337-2348 (2019-12-17)
Ethanol ablation, the injection of ethanol to induce necrosis, was originally used to treat hepatocellular carcinoma, with survival rates comparable to surgery. However, efficacy is limited due to leakage into surrounding tissue. To reduce leakage, we previously reported incorporating ethyl
Kifayat Ullah Shah et al.
TheScientificWorldJournal, 2012, 842348-842348 (2012-06-01)
The design and fabrication of sustained/controlled release dosage forms, employing new excipients capable of extending/controlling the release of drugs from the dosage forms over prolonged periods, has worked well in achieving optimally enhanced therapeutic levels of the drugs. In this
Ghulam Murtaza
Acta poloniae pharmaceutica, 69(1), 11-22 (2012-05-12)
Ethylcellulose (EC) based microencapsulated drug delivery systems are being extensively studied throughout the world for achieving extended drug release and protecting the core substance from degradation. The in vitro evaluation of EC microcapsules have elucidated that their particle characteristics are
Oguzhan Gunduz et al.
Pharmaceutical research, 30(1), 225-237 (2012-09-08)
To investigate a new microfluidic method for the continuous preparation of hollow-shell nanoparticles of a hydrophobic polymer and the simultaneous encapsulation within these of a hydrophilic active pharmaceutical ingredient. A specially designed and constructed microfluidic device which facilitates at a
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service